Arzeda Company
Arzeda develops enzyme design technology to create entirely novel designer cell factories capable of industry-scale chemical production.
Investors
Founded Date:
2008-01-01
Last Funding Type:
Series B
Headquarters:
Seattle, Washington, United States
Investors Number:
13.0
Technology:
Biotechnology, Information Services, Information Technology, Manufacturing
Employee Number:
11-50
Industry:
Early Drug Development
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-03-29
Funding Status:
Early Stage Venture
Total Funding:
51447828.0